510(k) K173871
K173871 is an FDA 510(k) premarket notification submitted by Suzhou Hengrui Callisyn Biomedical Co., Ltd. for the device "CalliSpheres Embolic Microspheres, 8Spheres Embolic Microspheres". The FDA issued a decision of Substantially Equivalent on September 17, 2018. The device falls under product code NAJ (Agents, Embolic, For Treatment Of Uterine Fibroids), a Class II device regulated under 21 CFR 870.3300.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 17, 2018
- Date Received
- December 20, 2017
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Agents, Embolic, For Treatment Of Uterine Fibroids
- Device Class
- Class II
- Regulation Number
- 870.3300
- Review Panel
- OB
- Submission Type